Form 4: IGM Biosciences Executive Decker Lisa Lynn Reports Changes in Beneficial Ownership
SEC Filing
Lisa Lynn Decker, Chief Business Officer of IGM Biosciences, reports transactions involving restricted stock units and stock options, including an option exchange program.
Summary
- Lisa Lynn Decker, the Chief Business Officer of IGM Biosciences, filed a Form 4 detailing changes in her beneficial ownership of the company's stock.
- On July 19, 2024, Decker acquired 16,666 restricted stock units (RSUs) that vest over time, with the first half vesting on July 19, 2025, and the remainder vesting quarterly thereafter.
- She also acquired 3,334 RSUs that vest starting January 19, 2026, with the remaining vesting quarterly.
- These RSU grants were issued as part of an option exchange program where Decker's options to purchase 60,000 shares were cancelled.
- Following these transactions, Decker directly owns 80,029 shares of IGM Biosciences common stock.
- She also holds options to purchase 0 shares of common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of insider transactions. There's no indication of positive or negative implications for the company's performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be informative for investors.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 07/19/2024 | Date of earliest transaction: Acquisition of RSUs and cancellation of stock options. |
| 07/19/2025 | Vesting date for one-half of the 16,666 RSUs. |
| 01/19/2026 | Vesting date for one-half of the 3,334 RSUs. |
| 03/15/2031 | Expiration date of the cancelled stock options. |
| 07/23/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.